Related Experiment Video
Updated: Jul 6, 2025

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation
James Cairns1, Tanya Lei Feng2, May C Ong3
1Neurology, The University of British Columbia, Faculty of Medicine, Vancouver, British Columbia, Canada.
Abstract:
We discuss the use of an inpatient multi-day continuous intravenous ketamine infusion for the treatment of opioid-induced hyperalgesia (OIH) and high fentanyl requirements in the case of a patient with a background of fibromyalgia/central sensitisation syndrome who underwent a complicated post-operative course following a right below-knee amputation for high-grade myxoid fibrosarcoma. The patient was successfully tapered off a total fentanyl patch dose of 162 mcg/hour every 72 hours (morphine equivalent dose of 389 mg/day) to short-acting hydromorphone 2 mg orally two times per day as needed (equivalent of 8 mg morphine sustained-release twice per day) during a 2-week admission with only mild withdrawal symptoms. We discuss the pharmacology of ketamine and its possible application in the treatment of OIH.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Parenteral Anesthetics: Overview
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Opioid Analgesics: Morphine and Other Natural Cogeners

